Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000292810 | SCV000408831 | uncertain significance | Smith-McCort dysplasia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000333578 | SCV000408832 | uncertain significance | Dyggve-Melchior-Clausen syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004021732 | SCV004780444 | uncertain significance | DYM-related disorder | 2024-02-14 | no assertion criteria provided | clinical testing | The DYM c.920C>T variant is predicted to result in the amino acid substitution p.Ala307Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.012% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |